Integrated DNA Technologies expands synthetic biology portfolio
New collaboration empowers customers with sequence-perfect constructs as long as 50 kb
19 Jan 2026Product news
Integrated DNA Technologies (IDT), a Danaher company, and Ansa Biotechnologies, Inc., has announced a strategic collaboration that adds new complementary capabilities to IDT’s synthetic biology portfolio.
Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers, enabling researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications.
Ansa's proprietary enzymatic platform provides both the length and complexity needed to design and assemble critical DNA constructs at scale. Ansa’s sustainable approach uses no harsh chemicals, preserving DNA integrity while enabling the synthesis of longer, more complex sequences.
Exclusively manufactured in the United States, Ansa’s DNA products integrate seamlessly into existing workflows while empowering the next wave of biological discovery.
The partnership prioritizes the delivery of a new standard for speed, precision, and reliability. Each sequence is rigorously verified and optimized for GC content, homopolymers, and repetitive elements to give researchers confidence that their designs are accurate, which helps to minimize rework, troubleshooting, and downstream risk.
“Customers face unprecedented complexity in their research, and they deserve solutions that make progress simpler and faster,” said IDT President Ajay Gannerkote. “IDT’s partnership with Ansa reflects the combination of proven reliability and trust with innovation in synthetic biology to deliver exactly that. This collaboration will help ensure researchers can come to IDT for their needs across every dimension of complexity, enabling breakthroughs that truly matter.”
Jason T. Gammack, Chief Executive Officer of Ansa, commented, “Ansa was founded to solve the hardest problems in DNA synthesis: length, complexity, and reliability. Through our collaboration with IDT, we are dismantling long-standing technical barriers and enabling more researchers worldwide to push the boundaries of science with greater confidence and without compromise.”